FRNM

Freenome, Inc. - Common stock (FRNM)

About Freenome, Inc. - Common stock (FRNM)

Freenome, Inc. operates as an early detection company, which engages in the development of blood-based screening tests to detect cancer. Its proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. The company was founded by Riley Ennis in 2014 and is headquartered in Brisbane, CA.

Details

Daily high
$10.36
Daily low
$9.60
Price at open
$9.83
52 Week High
$17.50
52 Week Low
$9.60
Market cap
1.1B
Dividend yield
-
Volume
1.1M
Avg. volume
781,210
P/E ratio
19.75

Freenome, Inc. - Common stock News

Details

Daily high
$10.36
Daily low
$9.60
Price at open
$9.83
52 Week High
$17.50
52 Week Low
$9.60
Market cap
1.1B
Dividend yield
-
Volume
1.1M
Avg. volume
781,210
P/E ratio
19.75